updated 9/20/2010 12:46:33 PM ET 2010-09-20T16:46:33

CHARLESTON, S.C., Sept. 20, 2010 (GLOBE NEWSWIRE) -- Today, Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCBB:RMCP) filed suit in Charleston County Common Pleas Court against Philip Maurice Hicks (a.k.a. "Marty Hicks) for libel. According to the complaint, Hicks, using the alias "tazmanian353" on two Internet message boards, is alleged to be waging a cyber smear campaign in an effort to destroy RMCP and its corporate management, particularly the company's chief executive officer, Rondald Wheet.

"If you want to get very aggressive with this company," reads one posting by tazmanian353 on RagingBull.com, "buy a small amount of stock in it and I'll show you how to destroy Ron [Wheet.] Trust me, I am."

The complaint alleges Hicks committed multiple counts of libel by falsely accusing Wheet, company president, Thomas O'Brien and RMCP of violations of securities law in a number of postings on the investor message boards of  RagingBull.com and Yahoo!Finance relating to RMCP. Further, Hicks falsely accuses Wheet and O'Brien of fraud, assault, identity theft, racketeering, and theft of intellectual property, among other crimes, in order to advance an elaborate "pump and dump" stock scheme.

"As RevMed executes its business plans the shorters, who only profit from the stock declining, whose motives are self serving, continue to lose all creditability. However, the shorters need to recognize that when a line is crossed the company will take appropriate action," says Ron Wheet, CEO.

The complaint seeks unspecified actual and punitive damages from Hicks, as well as injunctive relief requiring the removal of the libelous postings and enjoining Hicks from further libelous activity.

Headquartered on Daniel Island, Revolutions Medical is a safety medical device and software application company. Its products include the FDA-approved RevVac safety syringe. Last week, RMCP finalized an agreement with Medical Investment Group to manufacture a minimum of five million 3cc safety syringes per month for a period of five years.

About Revolutions Medical Corporation

Revolutions Medical is a safety medical device and software application company. Its products include the RevVac safety syringe (FDA approved), safety blood drawing device and safety IV catheter. The Company also provides RevColor, RevDisplay and Rev3D -- software solutions and proprietary tools that are compatible with standard MRIs and standard PACS. The software suite's functionality includes sorting of images, color, 3D and automatic segmentation of images.

For additional information, please visit Revolutions Medical corporate website: http://www.revolutionsmedical.com

Investor Resource Center

CEO Ron Wheet Audio Interview:


RevVac Safety Syringe Demonstration Video:


RevColor MRI Video:


To be added to the Revolutions Medical investor email list, please email Skey@revolutionsmedical.com with RMCP in the subject line.

Become a RevMed fan and follow the Company on Facebook -- visit http://www.Facebook.com/Revmed


The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.

© Copyright 2012, GlobeNewswire, Inc. All Rights Reserved


Discussion comments


Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 3.79%
$30K home equity loan FICO 4.99%
$75K home equity loan FICO 4.69%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 13.83%
Cash Back Cards 17.80%
Rewards Cards 17.18%
Source: Bankrate.com